Current disease status-In remission - Page 7 of 7 Posts on Medivizor
Navigation Menu

Current disease status-In remission Posts on Medivizor

Efficacy and adherence to a lifestyle modification program in sedentary colorectal cancer survivors

Efficacy and adherence to a lifestyle modification program in sedentary colorectal cancer survivors

Posted by on Mar 7, 2013 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the efficacy of home-based lifestyle counseling and coaching program in achieving adequate lifestyle changes in older sedentary colorectal cancer (CRC) survivors.  Some background Older CRC survivors are at risk of developing secondary cancers, heart diseases and declining self-care capacity. Previous...

Read More

Targeting prostate cancer with gold nanoparticles

Posted by on Mar 3, 2013 in Prostate cancer | 0 comments

This article presents the novel concept of treating prostate cancer with radioactive gold nanoparticles.   Nanoparticles are extremely small engineered structures that can be used to deliver treatments to otherwise inaccessible areas of the body. Radiation therapy for prostate cancer is currently given using many techniques, each of them having...

Read More

Evaluating quality of life and adverse effects of proton therapy in young men with prostate cancer

Evaluating quality of life and adverse effects of proton therapy in young men with prostate cancer

Posted by on Feb 26, 2013 in Prostate cancer | 0 comments

The present study evaluated the quality of life and adverse effects for patients younger than 60 with prostate cancer following proton therapy. The main findings were that young prostate cancer patients treated with proton therapy have great outcomes with respect to urinary and sexual function. The prostate is a small gland only found in men that has...

Read More

High intensity focused ultrasound: a treatment option for men with recurrent, localized prostate cancer previously treated with radiation

High intensity focused ultrasound: a treatment option for men with recurrent, localized prostate cancer previously treated with radiation

Posted by on Feb 25, 2013 in Prostate cancer | 0 comments

In a nutshell This paper evaluated the use of High Intensity Focused Ultrasound (HIFU) to treat recurrent prostate cancers that are confined to the prostate gland (T1 and T2) and that have previously been treated with External Beam Radiation Therapy (EBRT). HIFU treatment has led to minimal PSA levels, and negative biopsies in about 58% of the...

Read More

New hormonal therapy protocol of for patients with rising PSA after radiotherapy

New hormonal therapy protocol of for patients with rising PSA after radiotherapy

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared intermittent versus continuous androgen deprivation therapy (ADT) for localized (confined) prostate cancer due to prostate-specific antigen (PSA) elevation after radiotherapy. Main findings: Intermittent ADT was not inferior compared to continuous therapy with respect to survival. However, some quality of life...

Read More

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study compared survivors of prostate cancer (PC) to patients of similar sexes and ages that have not had prostate cancer (non-cancer controls) based on the effects of prior treatments and treatment options on sexual, urinary, bowel and hormone functions. The main finding was that PC survivors had poorer sexual and urinary...

Read More

Detecting cancer cells in the blood stream as means to predict recurrence

Detecting cancer cells in the blood stream as means to predict recurrence

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated whether the presence of cancer cells in the blood stream predicts a worse prognosis in women with operable breast cancer. The main finding was that progression-free survival (time before cancer progression) and overall survival were lower if circulating cancer cells were detected in the blood. Some background...

Read More